Subsequently, ATP13A2 mutations were reported in Neuronal Ceroid Lipofuscinosis (NCL) and amyotrophic lateral sclerosis (ALS; Farias et al., 2011; Spataro et al., 2019). This evidence concerns the gene ATP13A2 and neuronal ceroid lipofuscinosis.